NEW YORK (GenomeWeb) – Rosetta Genomics today announced that it has signed an agreement-in-principle with cytology laboratory FNApath to provide thyroid cancer testing services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.